Effects of Fosfomycin and ImipenemCilastatin on the Nephrotoxicity of Vancomycin and Cisplatin in Rats
Authors: Nakamura T.1; Kokuryo T.1; Hashimoto Y.1; Inui K-i.1
Source: Journal of Pharmacy and Pharmacology, Volume 51, Number 2, 1 February 1999 , pp. 227-232(6)
Publisher: Pharmaceutical Press
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Abstract:
The nephrotoxicity of vancomycin and cisplatin and the protective effects of fosfomycin and imipenemcilastatin on renal function have been studied in rats. The renal clearance of vancomycin after the induction of renal dysfunction was also evaluated by calculating the glomerular filtration rate (GFR) and its secretory clearance.Plasma concentrations of creatinine and urea nitrogen increased dose-dependently after vancomycin injection. No such increases were observed after co-treatment with fosfomycin or imipenemcilastatin. Changes ofN-acetyl-
-D-glucosaminidase activity in the urine of vancomycin-treated rats were not remarkable compared with those in cisplatin-treated animals. The reduced renal clearance of vancomycin in rats with acute renal failure induced by vancomycin was because of a decrease in both GFR and secretory clearance. However, the changes in GFR and secretory clearance were not proportionalthe change in GFR was more pronounced than that of secretory clearance in the experimental groups. In addition, the renal clearance of vancomycin was maintained at the control level after co-administration of fosfomycin or imipenemcilastatin with vancomycin.These results suggest that vancomycin impairs glomerular filtration more markedly than renal tubular function as compared with cisplatin. Co-administration with fosfomycin or imipenemcilastatin confers significant protection against the nephrotoxic effects of vancomycin.
Document Type: Research article
DOI: 10.1211/0022357991772187
Affiliations: 1: Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan, 606-8507
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content

Click here for Page Help